SCHEMBL25528706

SCHEMBL25528706

CC(=O)COc1cc(Cl)c(Cc2ccc(O)c(-c3ccccc3)c2)c(Cl)c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
THRA P10827 11/20 0.57
THRB P10828 11/20 0.57
USP2 O75604 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
BACE1 P56817 1/20 0.42
PDCD1 Q15116 2/20 0.41
CD274 Q9NZQ7 2/20 0.41
ADORA3 P0DMS8 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
ERCC1 P07992 1/20 0.39
ERCC4 Q92889 1/20 0.39
PLA2G10 O15496 1/20 0.39
PLA2G2A P14555 1/20 0.39
FFAR1 O14842 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30574232 0.91 THRA (0.66) THRATHRBBACE1PLA2G10PLA2G2A
SCHEMBL23003630 0.91 THRA (0.66) THRATHRBBACE1PLA2G10PLA2G2A
SCHEMBL25528534 0.90 THRA (0.50) THRATHRBUSP2ALDH1A1HPGD
SCHEMBL25528562 0.90 THRA (0.52) THRATHRBPLA2G10PLA2G2A
SCHEMBL25528523 0.89 THRA (0.51) THRATHRBPLA2G10PLA2G2AFFAR1
SCHEMBL31350385 0.89 THRA (0.56) THRATHRBALDH1A1NPC1RAB9A
SCHEMBL31350423 0.88 THRA (0.55) THRATHRBALDH1A1BACE1PLA2G10
SCHEMBL25528524 0.88 THRA (0.51) THRATHRBPLA2G10PLA2G2AFFAR1
SCHEMBL25528539 0.88 THRA (0.50) THRATHRB
SCHEMBL25528533 0.88 THRA (0.51) THRATHRBALDH1A1ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667606-B2 Thyromimetics AUTOBAHN THERAPEUTICS, INC. (US) 2023-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667606-B2 Thyromimetics TPO, TSHR, TTR THRA 4/4885THRB 9/4885USP2 3776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.